Abbott cardiac moves, investments to boost Healthy China 2030

Chicago-headquartered health technologies firm Abbott said it will expand coverage and resources in training programs in China, as well as support Chinese doctors' clinical research, as it steps up efforts to fulfill its local commitments to achieve the goal of Healthy China 2030.

Through increasing resources, the leader in cardiovascular treatment industry aims at improving the sector's diagnosis and treatment level and strengthening primary care in China, in order to better serve Chinese cardiovascular patients, said the company's senior executives.

William Yu, deputy vice-president of Abbott Cardiac Rhythm Management, Asia Pacific, said: "China is one of the largest markets for cardiovascular disease. The demands from patients to be treated are huge, just as the demands from doctors to get trained. This is why we are constantly expanding our investment in China."